Revisor Wealth Management LLC Boosts Stake in Cardinal Health, Inc. (NYSE:CAH)

Revisor Wealth Management LLC increased its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 78.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,281 shares of the company's stock after purchasing an additional 1,879 shares during the quarter. Revisor Wealth Management LLC's holdings in Cardinal Health were worth $590,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Norges Bank purchased a new stake in shares of Cardinal Health during the 4th quarter valued at about $246,748,000. Marshall Wace LLP grew its position in Cardinal Health by 154.6% during the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock valued at $372,756,000 after buying an additional 1,913,892 shares during the period. Castlekeep Investment Advisors LLC purchased a new stake in Cardinal Health during the fourth quarter valued at approximately $141,963,000. GAMMA Investing LLC raised its position in Cardinal Health by 17,589.1% in the first quarter. GAMMA Investing LLC now owns 964,941 shares of the company's stock worth $132,940,000 after acquiring an additional 959,486 shares during the period. Finally, Junto Capital Management LP bought a new position in Cardinal Health in the fourth quarter worth approximately $92,811,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Performance

NYSE CAH traded up $2.82 during trading on Friday, hitting $164.80. The stock had a trading volume of 1,234,057 shares, compared to its average volume of 2,246,270. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $168.44. The stock has a 50 day simple moving average of $155.58 and a 200 day simple moving average of $137.45. The stock has a market capitalization of $39.33 billion, a price-to-earnings ratio of 25.71, a P/E/G ratio of 1.63 and a beta of 0.68.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The company had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. During the same quarter in the previous year, the business earned $2.08 EPS. Cardinal Health's revenue was up .0% compared to the same quarter last year. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.5107 per share. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a yield of 1.24%. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.83%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CAH. Bank of America boosted their price objective on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. Wall Street Zen raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Monday, May 5th. Morgan Stanley set a $181.00 price objective on Cardinal Health and gave the company an "overweight" rating in a research report on Friday, June 13th. Citigroup reissued a "neutral" rating and set a $170.00 price target (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Finally, Robert W. Baird lifted their price target on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $157.43.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.